{"url_path":"/sec/crvo/10-q/2026/item-1","section_key":"item-1","section_title":"Item 1 **","topic":"sec","document":{"doc_type":"10-Q","doc_date":"2026-05-15","source_url":"https://www.sec.gov/Archives/edgar/data/1053691/0001437749-26-017236-index.html","accession_number":"0001437749-26-017236","cik":"0001053691","ticker":"CRVO","issuer_name":"CervoMed Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1053691/0001437749-26-017236-index.html","primary_entity_key":"0001053691","primary_entity_name":"CervoMed Inc."},"word_count":39,"has_tables":true,"body_markdown":"**ITEM 1.**\n\n**LEGAL PROCEEDINGS**\n\n \n\nPlease refer to *Note 8, Commitments and Contingencies* in the notes accompanying the unaudited condensed consolidated interim financial statements included in Part I, Item 1 of this Quarterly Report, which is incorporated herein by reference."}